-
ALNY Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Alnylam Pharmaceuticals (ALNY)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.10 bn | 1.10 bn | 1.10 bn | 1.10 bn | 1.10 bn | 1.10 bn |
Cash burn (monthly) | (no burn) | (no burn) | 36.22 mm | 21.78 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 154.25 mm | 92.74 mm | n/a | n/a |
Cash remaining | n/a | n/a | 948.24 mm | 1.01 bn | n/a | n/a |
Runway (months of cash) | n/a | n/a | 26.2 | 46.4 | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 560 |
Opened positions | 104 |
Closed positions | 66 |
Increased positions | 213 |
Reduced positions | 168 |
13F shares | Current |
---|---|
Total value | 31.18 tn |
Total shares | 121.47 mm |
Total puts | 1.12 mm |
Total calls | 1.23 mm |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Capital World Investors | 16.51 mm | $4.54 tn |
FMR | 14.67 mm | $4.04 tn |
Vanguard | 12.64 mm | $3.48 tn |
BlackRock | 9.71 mm | $2.67 tn |
Capital Research Global Investors | 5.24 mm | $1.44 tn |
Wellington Management | 4.95 mm | $1.36 tn |
Baillie Gifford & Co | 4.89 mm | $1.34 tn |
Capital International Investors | 3.97 mm | $1.09 tn |
Dodge & Cox | 3.62 mm | $996.31 bn |
STT State Street | 3.47 mm | $953.89 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jan 25 | Pushkal Garg | Common Stock | Sell | Dispose S | No | Yes | 285 | 52,592 | 14.99 mm | 11,989 |
27 Jan 25 | Pushkal Garg | Common Stock | Option exercise | Acquire M | No | Yes | 88.95 | 25,000 | 2.22 mm | 64,581 |
27 Jan 25 | Pushkal Garg | Common Stock | Option exercise | Acquire M | No | Yes | 88.95 | 23,876 | 2.12 mm | 39,581 |
27 Jan 25 | Pushkal Garg | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 88.95 | 23,876 | 2.12 mm | 0 |
27 Jan 25 | Pushkal Garg | Performance Stock Option 2015 Common Stock | Option exercise | Dispose M | No | Yes | 88.95 | 25,000 | 2.22 mm | 0 |
23 Jan 25 | Sharp Phillip A | Common Stock | Sell | Dispose S | No | Yes | 275 | 11,250 | 3.09 mm | 0 |
23 Jan 25 | Sharp Phillip A | Common Stock | Option exercise | Acquire M | No | Yes | 131.21 | 11,250 | 1.48 mm | 11,250 |
23 Jan 25 | Sharp Phillip A | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 131.21 | 11,250 | 1.48 mm | 0 |
12 Dec 24 | Pushkal Garg | Common Stock | Sell | Dispose S | No | Yes | 255.8 | 1 | 255.80 | 15,705 |
12 Dec 24 | Pushkal Garg | Common Stock | Sell | Dispose S | No | Yes | 254.37 | 140 | 35.61 k | 15,706 |